| Wilson Deshon Christian Iv, CRNA | |
|
108 Oxford Ct, Goodlettsville, TN 37072-2145 | |
| (601) 917-6863 | |
| Not Available |
| Full Name | Wilson Deshon Christian Iv |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 11 Years |
| Location | 108 Oxford Ct, Goodlettsville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932528296 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkridge Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Anesthesiology Of Tennessee Pc | 9931001922 | 382 |
News Archive
Dana Farber/Harvard Cancer Center will launch a new multi-million dollar grant award program focused on prostate cancer research. It will be administered in collaboration with the Prostate Cancer Foundation.
David Feola, a University of Kentucky College of Pharmacy faculty member in the Department of Pharmacy Practice and Science, received a five-year, $1.8 million grant from the National Institutes of Health (NIH) to continue his research investigating immune responses in the lungs that will potentially lead to the discovery of medical treatments for patients with cystic fibrosis and other chronic pulmonary inflammatory conditions.
Novartis announced today that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Pharmaceutical and healthcare market research company Manhattan Research releases its latest Taking the Pulse Europe study, which explores how physicians in Germany, Spain, France, Italy, and the United Kingdom use the Internet and technology for their practices and professional purposes.
One-year follow-up data from 907 Japanese patients who received the Zilver® PTX® drug-eluting stent showed positive results in keeping open the superficial femoral artery (SFA). The postmarket surveillance (PMS) study, designed to evaluate the stent's performance in real-world patient use, was presented at the 2014 Euro PCR meeting.
› Verified 9 days ago
| Entity Name | Anesthesia Medical Group, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215932413 PECOS PAC ID: 6901702307 Enrollment ID: O20031208000822 |
News Archive
Dana Farber/Harvard Cancer Center will launch a new multi-million dollar grant award program focused on prostate cancer research. It will be administered in collaboration with the Prostate Cancer Foundation.
David Feola, a University of Kentucky College of Pharmacy faculty member in the Department of Pharmacy Practice and Science, received a five-year, $1.8 million grant from the National Institutes of Health (NIH) to continue his research investigating immune responses in the lungs that will potentially lead to the discovery of medical treatments for patients with cystic fibrosis and other chronic pulmonary inflammatory conditions.
Novartis announced today that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Pharmaceutical and healthcare market research company Manhattan Research releases its latest Taking the Pulse Europe study, which explores how physicians in Germany, Spain, France, Italy, and the United Kingdom use the Internet and technology for their practices and professional purposes.
One-year follow-up data from 907 Japanese patients who received the Zilver® PTX® drug-eluting stent showed positive results in keeping open the superficial femoral artery (SFA). The postmarket surveillance (PMS) study, designed to evaluate the stent's performance in real-world patient use, was presented at the 2014 Euro PCR meeting.
› Verified 9 days ago
| Entity Name | Nashville Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225081805 PECOS PAC ID: 1557350501 Enrollment ID: O20040601001098 |
News Archive
Dana Farber/Harvard Cancer Center will launch a new multi-million dollar grant award program focused on prostate cancer research. It will be administered in collaboration with the Prostate Cancer Foundation.
David Feola, a University of Kentucky College of Pharmacy faculty member in the Department of Pharmacy Practice and Science, received a five-year, $1.8 million grant from the National Institutes of Health (NIH) to continue his research investigating immune responses in the lungs that will potentially lead to the discovery of medical treatments for patients with cystic fibrosis and other chronic pulmonary inflammatory conditions.
Novartis announced today that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Pharmaceutical and healthcare market research company Manhattan Research releases its latest Taking the Pulse Europe study, which explores how physicians in Germany, Spain, France, Italy, and the United Kingdom use the Internet and technology for their practices and professional purposes.
One-year follow-up data from 907 Japanese patients who received the Zilver® PTX® drug-eluting stent showed positive results in keeping open the superficial femoral artery (SFA). The postmarket surveillance (PMS) study, designed to evaluate the stent's performance in real-world patient use, was presented at the 2014 Euro PCR meeting.
› Verified 9 days ago
| Entity Name | American Anesthesiology Of Tennessee Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609822998 PECOS PAC ID: 9931001922 Enrollment ID: O20040713001364 |
News Archive
Dana Farber/Harvard Cancer Center will launch a new multi-million dollar grant award program focused on prostate cancer research. It will be administered in collaboration with the Prostate Cancer Foundation.
David Feola, a University of Kentucky College of Pharmacy faculty member in the Department of Pharmacy Practice and Science, received a five-year, $1.8 million grant from the National Institutes of Health (NIH) to continue his research investigating immune responses in the lungs that will potentially lead to the discovery of medical treatments for patients with cystic fibrosis and other chronic pulmonary inflammatory conditions.
Novartis announced today that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Pharmaceutical and healthcare market research company Manhattan Research releases its latest Taking the Pulse Europe study, which explores how physicians in Germany, Spain, France, Italy, and the United Kingdom use the Internet and technology for their practices and professional purposes.
One-year follow-up data from 907 Japanese patients who received the Zilver® PTX® drug-eluting stent showed positive results in keeping open the superficial femoral artery (SFA). The postmarket surveillance (PMS) study, designed to evaluate the stent's performance in real-world patient use, was presented at the 2014 Euro PCR meeting.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wilson Deshon Christian Iv, CRNA 41 Mall Rd, Burlington, MA 01805-0001 Ph: (781) 744-8000 | Wilson Deshon Christian Iv, CRNA 108 Oxford Ct, Goodlettsville, TN 37072-2145 Ph: (601) 917-6863 |
News Archive
Dana Farber/Harvard Cancer Center will launch a new multi-million dollar grant award program focused on prostate cancer research. It will be administered in collaboration with the Prostate Cancer Foundation.
David Feola, a University of Kentucky College of Pharmacy faculty member in the Department of Pharmacy Practice and Science, received a five-year, $1.8 million grant from the National Institutes of Health (NIH) to continue his research investigating immune responses in the lungs that will potentially lead to the discovery of medical treatments for patients with cystic fibrosis and other chronic pulmonary inflammatory conditions.
Novartis announced today that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Pharmaceutical and healthcare market research company Manhattan Research releases its latest Taking the Pulse Europe study, which explores how physicians in Germany, Spain, France, Italy, and the United Kingdom use the Internet and technology for their practices and professional purposes.
One-year follow-up data from 907 Japanese patients who received the Zilver® PTX® drug-eluting stent showed positive results in keeping open the superficial femoral artery (SFA). The postmarket surveillance (PMS) study, designed to evaluate the stent's performance in real-world patient use, was presented at the 2014 Euro PCR meeting.
› Verified 9 days ago
Mr. Jonathan Wayne Burks, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3024 Business Park Cir, Goodlettsville, TN 37072 Phone: 615-239-2061 Fax: 615-296-9949 | |
Caroline Litchfield, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3024 Business Park Cir, Goodlettsville, TN 37072 Phone: 615-851-6033 Fax: 615-851-2018 | |
Katie H Hill, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3024 Business Park Cir, Goodlettsville, TN 37072 Phone: 615-851-6033 | |
Nan Kimbro, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3024 Business Park Cir, Goodlettsville, TN 37072 Phone: 615-851-6033 Fax: 615-851-2018 | |
John Matthew Bratcher, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3024 Business Park Cir, Goodlettsville, TN 37072 Phone: 615-851-6033 Fax: 615-851-2018 | |
Sammy Oldham, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3024 Business Park Cir, Goodlettsville, TN 37072 Phone: 615-851-6033 Fax: 615-851-2018 |